L. Mårtensson

Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.

B. Nilsson, G. Juliusson, M. Cragg, 2015, Cancer cell.

Domain binding and isotype dictate the activity of anti-human OX40 antibodies

M. Cragg, M. Glennie, R. French, 2020, Journal for ImmunoTherapy of Cancer.

Domain binding and isotype dictate the activity of anti-human OX40 antibodies

M. Cragg, M. Glennie, A. Tutt, 2020, Journal for ImmunoTherapy of Cancer.

A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.

F. Zhan, G. Tricot, Ye Yang, 2013, Cancer cell.